5-Bromo-6-methyl-3-nitropyridin-2-amine, 95.0%, 25g

2-Imidazolecarboxylic acid, 99.00%, 10g

tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate, 95.0%, 250mg

(-)-Nicotine, min. 99%, for biochemistry, 10 g, glass packaging

3,5-Difluoropyridine>98.0%(GC)1g

2-Bromo-4-(trifluoromethoxy)biphenyl, 95%, 1g

1-(4-(3-Chloropropoxy)-3-methoxyphenyl)ethanone, 95.0%, 250mg

(1R,2R)-2-(4'-(3-Phenylureido)-[1,1'-biphenyl]-4-carbonyl)cyclopentanecarboxylic acid, 98%, 50mg

Fmoc-Phe-Gly-OH, 25g

2-(Diphenylphosphino)benzaldehyde, 95.0%, 5g

2,6-Di(1H-pyrazol-1-yl)isonicotinic acid, 98%, 500mg

Ethyl 4-ethoxy-2-oxo-1,2-dihydropyridine-3-carboxylate, 95.0%, 1g

tert-Butyl (3aR,6aR)-3a-(hydroxymethyl)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95%, 500mg